Insider
| Ticker | Insider | Role | Type | Date | Shares | Price | Value | Notes | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ABUS | Androski Lindsay | President and CEO | Award | 2026-02-02 | 28,000 | — | — | Acquired | EDGAR |
| ABUS | Nguyen Tuan | Chief Financial Officer | Award | 2026-02-02 | 73,500 | — | — | Acquired | EDGAR |
| ABUS | McElhaugh Michael J. | Interim President & CEO | Award | 2025-02-14 | 177,000 | — | — | Acquired | EDGAR |
| ABUS | HASTINGS DAVID C | Chief Financial Officer | Award | 2025-02-14 | 90,100 | — | — | Acquired | EDGAR |
| ABUS | Sims Karen | Chief Medical Officer | Award | 2025-02-14 | 49,300 | — | — | Acquired | EDGAR |
| ABUS | Naftzger J. Christopher | General Counsel and CCO | Award | 2025-02-14 | 54,300 | — | — | Acquired | EDGAR |
| ABUS | Naftzger J. Christopher | General Counsel and CCO | Sale | 2025-02-04 | 11,333 | $3.28 | $37,206 | Disposed | EDGAR |
| ABUS | HASTINGS DAVID C | Chief Financial Officer | Sale | 2025-02-04 | 22,183 | $3.28 | $72,827 | Disposed | EDGAR |
| ABUS | Sims Karen | Chief Medical Officer | Sale | 2025-02-04 | 19,348 | $3.28 | $63,519 | Disposed | EDGAR |
| ABUS | McElhaugh Michael J. | Interim President & CEO | Sale | 2025-02-04 | 23,790 | $3.28 | $78,103 | Disposed | EDGAR |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status